Intrathecal Drug Market

Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations.
Intrathecal Drug Market aims to provide a comprehensive presentation of the global market for Intrathecal Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrathecal Drug. Intrathecal Drug Market contains market size and forecasts of Intrathecal Drug in global, including the following market information:
Global Intrathecal Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Intrathecal Drug Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Intrathecal Drug companies in 2022 (%)
The global Intrathecal Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Baclofen Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intrathecal Drug include Medtronic, Jazz Pharmaceuticals, West Ward Pharmaceutical, Saol Therapeutics, Piramal Critical Care and Fresenius Kabi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intrathecal Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intrathecal Drug Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Intrathecal Drug Market Segment Percentages, by Type, 2022 (%)
Baclofen Injection
Ziconotide Intrathecal Infusion
Morphine Injection
Global Intrathecal Drug Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Intrathecal Drug Market Segment Percentages, by Application, 2022 (%)
Adult
Child & Teen
Global Intrathecal Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Intrathecal Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intrathecal Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Intrathecal Drug revenues share in global market, 2022 (%)
Key companies Intrathecal Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Intrathecal Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Jazz Pharmaceuticals
West Ward Pharmaceutical
Saol Therapeutics
Piramal Critical Care
Fresenius Kabi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intrathecal Drug, market overview.
Chapter 2: Global Intrathecal Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Intrathecal Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intrathecal Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intrathecal Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.